EcoDrugPlus

Farnesyl Diphosphate Synthase

Ensembl ID : ENSCGOG00000006560
Gene Symbol: FDPS
3 Cross references
269 Possible Orthologues:

Farnesyl-Diphosphate Farnesyltransferase 1

Ensembl ID : ENSCGOG00000010611
Gene Symbol: FDFT1
3 Cross references
221 Possible Orthologues:

Farnesyltransferase, Caax Box, Alpha

Ensembl ID : ENSCGOG00000010402
Gene Symbol: FNTA
3 Cross references
222 Possible Orthologues:

Fibroblast Growth Factor Receptor 1-A-Like

Ensembl ID : ENSCGOG00000014985
Gene Symbol: LOC115013012
3 Cross references
208 Possible Orthologues:

Fibroblast Growth Factor Receptor 2

Ensembl ID : ENSCGOG00000013030
Gene Symbol: FGFR2
3 Cross references
221 Possible Orthologues:

Fibroblast Growth Factor Receptor 3-Like

Ensembl ID : ENSCGOG00000022164
Gene Symbol: LOC115027139
3 Cross references
191 Possible Orthologues:

Fms Related Tyrosine Kinase 1

Ensembl ID : ENSCGOG00000012713
Gene Symbol: FLT1
3 Cross references
199 Possible Orthologues:

Fms Related Tyrosine Kinase 4

Ensembl ID : ENSCGOG00000019882
Gene Symbol: FLT4
3 Cross references
197 Possible Orthologues:

Folate Hydrolase 1b

Ensembl ID : ENSCGOG00000015723
Gene Symbol: FOLH1B
3 Cross references
339 Possible Orthologues:

Folate Receptor Alpha-Like

Ensembl ID : ENSCGOG00000015593
Gene Symbol: LOC115017520
3 Cross references
436 Possible Orthologues:

Free Fatty Acid Receptor 2-Like

Ensembl ID : ENSCGOG00000018319
Gene Symbol: LOC115021086
2 Cross references
340 Possible Orthologues:

Fyn Related Src Family Tyrosine Kinase

Ensembl ID : ENSCGOG00000014554
Gene Symbol: FRK
3 Cross references
217 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).